Dr Agarwal's Hea

  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: INE943P01029
  • NSEID: AGARWALEYE
  • BSEID: 544350
INR
473.95
3.75 (0.8%)
BSENSE

Oct 09

BSE+NSE Vol: 2.57 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10039533,
    "name": "Dr Agarwal's Hea",
    "stock_name": "Dr Agarwal's Hea",
    "full_name": "Dr Agarwals Health Care Ltd",
    "name_url": "stocks-analysis/dr-agarwal-s-hea",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "473.95",
    "chg": 3.75,
    "chgp": "0.8%",
    "dir": 1,
    "prev_price": "470.20",
    "mcapval": "14,715.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 544350,
    "symbol": "AGARWALEYE",
    "ind_name": "Hospital",
    "ind_code": 94,
    "indexname": "India SENSEX",
    "isin": "INE943P01029",
    "curr_date": "Oct 09",
    "curr_time": "",
    "bse_nse_vol": "2.57 lacs",
    "exc_status": "Active",
    "traded_date": "Oct 09, 2026",
    "traded_date_str": "2026 10 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/dr-agarwal-s-hea-10039533-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 11,
    "sid": "10039533",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/dr-agarwals-health-care-10039533"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Oct-2026",
      "details": "Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended September 30 2026 is enclosed.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Scheme of Arrangement",
      "datetime": "05-Oct-2026",
      "details": "Receipt of sanction from the Honble NCLT Chennai Bench towards the scheme of amalgamation between Dr. Agarwals Eye Hospital Limited and Dr. Agarwals Health Care Limited and their respective Shareholders and Creditors.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Cessation",
      "datetime": "29-Sep-2026",
      "details": "Completion of Second Term of 5 (Five) Consecutive Years by Mr. Sanjay Anand (DIN: 02501139) Independent Director of the Company",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

07-Oct-2026 | Source : BSE

Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended September 30 2026 is enclosed.

Announcement under Regulation 30 (LODR)-Scheme of Arrangement

05-Oct-2026 | Source : BSE

Receipt of sanction from the Honble NCLT Chennai Bench towards the scheme of amalgamation between Dr. Agarwals Eye Hospital Limited and Dr. Agarwals Health Care Limited and their respective Shareholders and Creditors.

Announcement under Regulation 30 (LODR)-Cessation

29-Sep-2026 | Source : BSE

Completion of Second Term of 5 (Five) Consecutive Years by Mr. Sanjay Anand (DIN: 02501139) Independent Director of the Company

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available